Related Experiment Video
Updated: Apr 26, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
34.7K
[Sex and gender differences in pharmacotherapy].
1Institut für Geschlechterforschung in der Medizin (GIM), Charité-Universitätsmedizin Berlin, Hessische Straße 3-4, 10115, Berlin, Deutschland, Vera.Regitz-Zagrosek@charite.de.
Summary
Drug efficacy varies between sexes due to biological and gender differences. Optimizing drug therapy requires acknowledging and addressing these sex-specific variations for better patient outcomes.
Area of Science:
- Pharmacology and Toxicology
- Sex-Based Biology
- Clinical Drug Development
Context:
- Significant sex-based differences exist in drug pharmacokinetics (absorption, distribution, metabolism, excretion) and pharmacodynamics (efficacy).
- These biological disparities stem from sex-specific gene expression, epigenetic modifications, and hormonal influences.
- Sociocultural gender dimensions also impact drug efficacy and patient-provider interactions.
Purpose:
- To highlight the underestimation of sex and gender differences in drug development and clinical trials.
- To emphasize the need for prospective study designs that assess sex-specific drug effects.
- To underscore the importance of recognizing differential drug usage patterns (compliance, adherence, self-medication) between sexes.
Summary:
- Current drug testing often overlooks sex differences, leading to drugs optimized for only one sex.
- Clinical studies, including Phase III trials, have historically failed to prospectively evaluate sex-specific drug responses.
- Variations in how men and women use medications and how physicians treat patients contribute to suboptimal drug therapy.
Impact:
- There is a growing recognition of the necessity to tailor drug therapy to individual sexes for optimal efficacy and safety.
- Addressing sex and gender differences in drug development and clinical practice is crucial for personalized medicine.
- Future research and clinical guidelines must incorporate sex-specific considerations to improve therapeutic outcomes for all patients.
Related Concept Videos
01:27Panic Disorder
1.2K
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
1.2K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
365
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
365
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
156
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
379
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
379
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
01:19Factors Affecting Drug Biotransformation: Biological
911
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
911